Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01759277 · ClinicalTrials.gov registry record · Phase 4
Femoral Versus Adductor Canal Continuous Peripheral Nerve Blocks for Knee Arthroplasty
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT01759277 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 80 participants.
The verdict
NCT01759277, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
Patients typically experience moderate-to-severe pain following knee arthroplasty that is usually treated with a combination of oral and intravenous analgesics and enhanced by continuous peripheral nerve blocks. There are currently two locations to place a perineural catheter to provide analgesia following knee arthroplasty: a femoral nerve catheter and an adductor canal catheter. Both have been demonstrated to be effective following knee arthroplasty. However, it remains unknown if one location is superior to the other; or, more accurately, what the relative benefits are to each technique. While femoral CPNB has many benefits, one of the challenges of using this technique is that there is a decrease in quadriceps muscle strength which can be a limiting factor for rehabilitation. In contrast, the adductor canal catheter affects only the vastus medialis. This block may lessen block-induced quadriceps weakness following knee arthroplasty compared with a femoral infusion. The investigators hypothesize that compared with femoral perineural local anesthetic infusion, an adductor canal infusion is associated with a shorter time until four discharge criteria are met: (1) adequate analgesia; (2) independence from intravenous analgesics; (3) ability to ambulate 30 m; and (4) ability to stand, walk 3 m, and return to a sitting position without another's assistance.
Interventions
- DRUG Control: Femoral perineural local anesthetic infusion
- DRUG Experimental: Adductor Canal perineural local anesthetic infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01759277
The ClinicalTrials.gov registry entry for NCT01759277 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control: Femoral perineural local anesthetic infusion is the first listed.
NCT01759277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01759277 about?
NCT01759277 is a clinical study titled "Femoral Versus Adductor Canal Continuous Peripheral Nerve Blocks for Knee Arthroplasty". Patients typically experience moderate-to-severe pain following knee arthroplasty that is usually treated with a combination of oral and intravenous analgesics and enhanced by continuous peripheral nerve blocks. There are currently two locations to place a perineural catheter to provide analgesia fo...
What is the current status of trial NCT01759277?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2012-12. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01759277?
The interventions under investigation include: Control: Femoral perineural local anesthetic infusion (DRUG), Experimental: Adductor Canal perineural local anesthetic infusion (DRUG).
Who is sponsoring clinical trial NCT01759277?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.